PEPTIDE
Verified ComparisonLast updated: 21 April 2026

Mod GRF 1-29 vs CJC-1295

Mod GRF 1-29 (tetrasubstituted) is the modified form of GHRH(1-29) with enhanced stability. CJC-1295 is a long-acting depot analog. Both stimulate GH via GHRH.

Compound A

Mod GRF 1-29

GH Releasing

Evidence
4.2/ 5
A−

Compound B

CJC-1295

GH Releasing

Evidence
4.4/ 5
A
Editor's note
Mod GRF 1-29 enables pulsatile dosing; CJC-1295 provides sustained release in research protocols.
CriterionMod GRF 1-29CJC-1295
DurationHours (short-acting)Days (long-acting)
Dosing flexibilityMultiple daily doses2-3x weekly
GH pulse amplitudeAcute, controllableSustained elevation
Potency per doseModestHigh
Research protocol diversityHigh (pulsatile studies)High (chronic studies)

Frequently asked questions

Both; Mod GRF 1-29 for acute/pulsatile designs, CJC-1295 for sustained-elevation studies.

Want to read the full reviews?